LMAT - Engaging In Options Activity George LeMaitre Exercises Options Valued At $266K In LeMaitre Vascular | Benzinga
A large exercise of company stock options by George LeMaitre, Chairman and CEO at LeMaitre Vascular (NASDAQ:LMAT) was disclosed in a new SEC filing on March 26, as part of an insider exercise.
What Happened: LeMaitre, Chairman and CEO at LeMaitre Vascular, exercised stock options for 14,808 shares of LMAT stock. This information was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday. The exercise price of the options was $47.93 per share.
The latest update on Wednesday morning shows LeMaitre Vascular shares down by 0.0%, trading at $65.9. At this price, LeMaitre's 14,808 shares are worth $266,154.
All You Need to Know About LeMaitre Vascular
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.
Key Indicators: LeMaitre Vascular's Financial Health
Revenue Growth: LeMaitre Vascular's remarkable performance in 3 months is evident. ...